RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > UPDATED (2): EMA's Abadie Resigns as Chair of CHMP

UPDATED (2): EMA's Abadie Resigns as Chair of CHMP

Posted 05 April 2012 | By Alexander Gaffney, RAC 

The European Medicines Agency (EMA) announced 4 April that effective immediately, Eric Abadie, chair of the Committee for Medicinal Products for Human Use (CHMP), was resigning from his position.

"Executive Director Guido Rasi has accepted his resignation with immediate effect," wrote EMA in a press release.

In a statement to Reuters, a spokesman said the move was related to Abadie's position at French regulatory authority Afssaps, where he serves as a scientific advisor to the Director General. No other information was provided, but the agency is expected to make a statement on the matter on Thursday. [Update: Afssaps statement posted.]

EMA staff is on holiday until 10 April, and is unlikely to make a more in-depth statement until that time.

Afssaps was been under fire recently for its lack of oversight in the drug Mediator, which has been blamed for a number of deaths, and a breast implant product manufactured by the now-defunct medical device manufacturer Poly Implant Prothese.

Dr Tomas Salmonson, vice-chair of the CHMP, will lead the Committee in the meantime to ensure continuity of operations. EMA said it will be holding elections for the new chairman "in due course."

Abadie has been Chairman of CHMP since 2007, and was vice-chairman of CHMP from 2001-2007.

Read more:

Eric Abadie resigns as chair of the CHMP

Reuters - Chairman of top EU drugs committee quits suddenly

See all Regulatory Focus news about Afssaps

Regulatory Focus newsletters

All the biggest regulatory news and happenings.